Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01+0.03 (+3.30%)
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Cocrystal Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cocrystal Pharma's pe ratio was 96.7× on Jan 31, 2019.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 96.7× | −23.3 |
| 2018 | Dec 31, 2018 | 120.0× | – |
See a number that looks wrong?